Usana Health Sciences Shares Gain on 2Q Sales Bump

Dow Jones

2025/07/23

By Katherine Hamilton

Usana Health Sciences shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter.

The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year.

Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents.

Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before.

The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August.

Usana reiterated its full-year outlook.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

July 22, 2025 18:21 ET (22:21 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2553267126"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553267126\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553267126?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553267126","market":"sg","top_or_hot":-1,"title":"Usana Health Sciences Shares Gain on 2Q Sales Bump","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine <a href=\"https://laohu8.com/S/HBK\">Hamilton</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/USNA\">Usana Health Sciences</a> shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter. \n</p>\n<p>\n  The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year. \n</p>\n<p>\n  Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents. \n</p>\n<p>\n  Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before. \n</p>\n<p>\n  The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August. \n</p>\n<p>\n  Usana reiterated its full-year outlook. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 22, 2025 18:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Usana Health Sciences Shares Gain on 2Q Sales Bump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUsana Health Sciences Shares Gain on 2Q Sales Bump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-23 06:21</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine <a href=\"https://laohu8.com/S/HBK\">Hamilton</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/USNA\">Usana Health Sciences</a> shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter. \n</p>\n<p>\n  The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year. \n</p>\n<p>\n  Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents. \n</p>\n<p>\n  Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before. \n</p>\n<p>\n  The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August. \n</p>\n<p>\n  Usana reiterated its full-year outlook. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 22, 2025 18:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"USNA","symbol_name":"优莎娜","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2553267126","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553267126","pubTimestamp":1753222860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Usana Health Sciences shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter.The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year.Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents.Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before.The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"USNA":"优莎娜"},"translate_title":"Usana Health Sciences股价因第二季度销售额增长而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":1},"content_text":"By Katherine Hamilton\n\n\nUsana Health Sciences shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter. \n\n\n  The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year. \n\n\n  Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents. \n\n\n  Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before. \n\n\n  The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August. \n\n\n  Usana reiterated its full-year outlook. \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 22, 2025 18:21 ET (22:21 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}